Biotechnology
CVAC
5.34
price up icon0.09%   0.00
 

Curevac N V (CVAC)
full-star
loading
Überblick Nachrichten Preisverlauf Optionskette Warum fällt CVAC? Forum Prognose
Schlusskurs vom Vortag:
$5.34
Offen:
$5.32
24-Stunden-Volumen:
204.50K
Relative Volume:
0.42
Marktkapitalisierung:
$1.20B
Einnahmen:
$596.48M
Nettoeinkommen (Verlust:
$123.72M
KGV:
9.7374
EPS:
0.5484
Netto-Cashflow:
$106.59M
1W Leistung:
-0.65%
1M Leistung:
-1.93%
6M Leistung:
+50.14%
1J Leistung:
+93.66%
1-Tages-Spanne:
Value
$5.32
$5.36
1-Wochen-Bereich:
Value
$5.32
$5.38
52-Wochen-Spanne:
Value
$2.37
$5.72

Curevac N V Stock (CVAC) Company Profile

Name
Firmenname
Curevac N V
Name
Sektor
Healthcare (1137)
Name
Branche
Biotechnology (635)
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
1,088
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-18
Name
Neueste SEC-Einreichungen
Name
CVAC's Discussions on Twitter

Vergleichen Sie CVAC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CVAC
Curevac N V
 5.35 1.20B 596.48M 123.72M 106.59M 0.5484
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 423.18 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 635.96 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 436.74 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
 830.26 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
 182.24 40.44B 447.02M -1.18B -868.57M -6.1812

Curevac N V Stock (CVAC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-13 Herabstufung Jefferies Buy → Hold
2024-04-25 Herabstufung Leerink Partners Outperform → Market Perform
2023-06-08 Eingeleitet SVB Securities Outperform
2023-01-19 Hochstufung UBS Neutral → Buy
2023-01-09 Hochstufung Jefferies Hold → Buy
2022-01-21 Herabstufung BofA Securities Neutral → Underperform
2022-01-18 Eingeleitet JMP Securities Mkt Outperform
2021-10-22 Eingeleitet Deutsche Bank Hold
2021-06-17 Herabstufung BofA Securities Buy → Neutral
2021-04-26 Fortgesetzt Credit Suisse Underperform
2021-04-26 Eingeleitet Guggenheim Neutral
2020-12-10 Herabstufung Credit Suisse Neutral → Underperform
2020-09-08 Eingeleitet BofA Securities Buy
2020-09-08 Eingeleitet Credit Suisse Neutral
2020-09-08 Eingeleitet Jefferies Hold
Alle ansehen

Curevac N V Aktie (CVAC) Neueste Nachrichten

pulisher
06:45 AM

BioNTech (NASDAQ: BNTX) reports €1,518.9M revenue, net loss €28.7M; raises FY outlook - Stock Titan

06:45 AM
pulisher
05:29 AM

Relative strength of CureVac N.V. in sector analysisMarket Movers & AI Enhanced Execution Alerts - newser.com

05:29 AM
pulisher
05:02 AM

Understanding CureVac N.V.’s price movementPortfolio Value Summary & High Accuracy Trade Signal Alerts - newser.com

05:02 AM
pulisher
02:23 AM

Smart tools for monitoring CureVac N.V.’s price actionBuy Signal & Safe Capital Preservation Plans - newser.com

02:23 AM
pulisher
Nov 02, 2025

Historical volatility pattern of CureVac N.V. visualizedQuarterly Profit Report & Fast Gain Swing Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Using data tools to time your CureVac N.V. exitJuly 2025 Short Interest & Verified High Yield Trade Plans - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

How interest rate cuts could boost CureVac N.V. stockMarket Risk Summary & Weekly Momentum Stock Picks - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will CureVac N.V. stock benefit from green energy trendsMarket Growth Report & Real-Time Volume Analysis - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Why CureVac N.V. stock is a value investor pickWeekly Trend Report & Verified Technical Trade Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can CureVac N.V. stock resist market sell offsRisk Management & Technical Confirmation Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How currency fluctuations impact CureVac N.V. stock2025 AllTime Highs & Free Reliable Trade Execution Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is CureVac N.V. stock positioned for digital transformation2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

CureVac’s New mRNA Study: A Potential Game-Changer in Lung Cancer Treatment - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

CureVac Announces Extraordinary Meeting for Merger with BioNTech - MSN

Oct 30, 2025
pulisher
Oct 29, 2025

CureVac N.V. (NASDAQ:CVAC) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Oct 29, 2025
pulisher
Oct 28, 2025

Is CureVac N.V. stock supported by strong fundamentalsOptions Play & Safe Capital Growth Plans - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Analyzing net buyer seller activity in CureVac N.V.Options Play & Precise Trade Entry Recommendations - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Is CureVac N.V. stock ready for breakoutMarket Activity Report & Risk Controlled Swing Trade Alerts - fcp.pa.gov.br

Oct 27, 2025
pulisher
Oct 27, 2025

CureVac schedules extraordinary shareholder meeting for November 25 By Investing.com - Investing.com South Africa

Oct 27, 2025
pulisher
Oct 27, 2025

CureVac schedules extraordinary shareholder meeting for November 25 - Investing.com

Oct 27, 2025
pulisher
Oct 27, 2025

CureVac schedules extraordinary meeting; releases proxy and merger docs - Stock Titan

Oct 27, 2025

Finanzdaten der Curevac N V-Aktie (CVAC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie CVAC

biotechnology RPRX
$37.23
price down icon 0.68%
biotechnology INCY
$92.89
price down icon 0.72%
biotechnology GMAB
$28.92
price up icon 0.96%
biotechnology BNTX
$104.23
price up icon 0.19%
biotechnology ONC
$312.02
price up icon 0.74%
biotechnology INSM
$182.66
price down icon 3.82%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):